‹ All stocks
Liquidia
LQDA · NASDAQ · Healthcare
$56.19
▼ $0.18 (-0.32%)
Day range
$55.92 – $57.21
Year range
$22.31 – $93.61
Open
$56.49
Previous close
$56.37
Market cap
$5.06B
Volume (24h)
$118.1K
Volume (52w)
$6.63M
Performance
7D
▲ 9.32%
1M
▲ 64.64%
3M
▼ -25.41%
6M
▼ -9.33%
1Y
▲ 97.85%
YTD
▲ 78.95%
3Y
▲ 764.47%
5Y
▲ 1116.24%
All-time
▲ 406.22%
Key statistics
P/E ratio
-45.68
EPS (TTM)
$-1.23
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
90.1M
About Liquidia
Liquidia Corporation operates as a biopharmaceutical enterprise, concentrating on the development, production, and market introduction of various treatments aimed at fulfilling critical patient requirements throughout the United States. A key asset in its developmental portfolio is YUTREPIA, an innovative inhaled dry powder version of treprostinil, intended for managing pulmonary arterial hypertension. Beyond its pipeline, the company also distributes a generic treprostinil injection within the U.S. market. Founded in 2004, Liquidia Corporation's main office is located in Morrisville, North Carolina.
Visit websiteCountry: United States of America
Related news
Liquidia Stock Surges: What It Means for Investors and the Market
Liquidia's stock has seen significant gains today, driven by positive market sentiment and strategic developments. This surge may have broa…
Liquidia Set for Potential 6.5% Stock Movement Ahead of Earnings Release
Liquidia Holdings is poised for a significant stock movement, with analysts predicting a 6.5% shift following its earnings release on Novem…
Alibaba's AI Glasses Boost Stock; Liquidia's Legal Win Sparks Rally
Alibaba's stock sees a surge following the announcement of innovative AI glasses, while Liquidia's shares climb after a favorable legal rul…
Liquidia Shares Soar After Settlement with United Therapeutics
Liquidia Technologies' stock price jumped to a five-month high following a settlement with United Therapeutics, signaling potential shifts …
Liquidia Stock Surges: What It Means for Investors and the Market
Liquidia's stock has seen a significant surge, driven by recent developments that could reshape its market position. This movement highligh…
More in Healthcare
LLY Eli Lilly and Company |
$1404.27 | -1.91% |
JNJ Johnson & Johnson |
$278.36 | -1.48% |
ABBV AbbVie |
$292.06 | -0.85% |
MRK Merck & Co. |
$143.45 | -0.70% |
UNH UnitedHealth Group Incorp… |
$388.49 | -5.71% |